Vivos Therapeutics, Inc. · NASDAQ:VVOS
Dawei Luo reported a 8.52% stake in Vivos Therapeutics, Inc. (Schedule 13G)
Event Jul 8, 2025 · Filed Jul 14, 2025
Dawei Luo reported a 8.52% stake in Vivos Therapeutics, Inc., 572,016 shares, as a passive investor on Jul 8, 2025. Filed Jul 14, 2025 (Schedule 13G).
- Stake
- 8.52%
- Shares
- 572,016
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Dawei Luo | 8.52% | 572,016 |
Source
Related
- Vivos Therapeutics, Inc.
- Dawei Luo
- Vivos Therapeutics, Inc. shareholders
- Form 4 · Huntsman Ronald Kirk · Sep 18, 2026
- Schedule 13G/A · Streeterville Capital LLC · Sep 3, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026